Pfizer's keys to juggling 8 U.S. launches? Organization, accountability, clear goals

Think you’re busy? Take a look at Pfizer’s commercial team for oncology, which is currently launching four new drugs, three new indications for older drugs, and a biosimilar. And that’s just in the U.S.